Vascepa Patient Counseling Information

Advise the patient to read the FDA-approved patient labeling before starting VASCEPA (Patient Information).
Inform patients that VASCEPA may increase their risk for atrial fibrillation or atrial flutter [see Precautions].
Inform patients with known hypersensitivity to fish and/or shellfish about the potential for allergic reactions to VASCEPA and advise them to discontinue VASCEPA and seek medical attention if any reactions occur [see Precautions].
Inform patients that VASCEPA may increase their risk for bleeding, especially if they are receiving other antithrombotic agents [see Precautions].
Advise patients to swallow VASCEPA capsules whole. Do not break open, crush, dissolve, or chew VASCEPA [see Dosage & Administration].
Instruct patients to take VASCEPA as prescribed. If a dose is missed, patients should take it as soon as they remember. However, if they miss one day of VASCEPA, they should not double the dose when they take it.